Blaine Labs Recalls Wound Care Gel Products Due to Microbial Contamination

The recall affects three lot numbers of 1 oz. and 3 oz. Revitaderm and Tridergel Wound Care Gel products.

Apr. 8, 2026 at 6:34pm

Got story updates? Submit your updates here. ›

A translucent, ghostly X-ray photograph of a medical gel container, revealing its internal structure in glowing lines against a dark background, conceptually illustrating the microbial contamination issue.An X-ray image of a contaminated wound care gel product highlights the need for rigorous quality control in the medical supplies industry.Santa Fe Springs Today

Blaine Labs, Inc. is voluntarily recalling three lot numbers of its Wound Care Gel products, 1 oz. and 3 oz. (0.1% Benzalkonium Chloride), due to the detection of microbial contamination with Lysinibacillus fusiformis, an environmental organism. The recall is a precautionary measure, as the contamination may pose a risk of infection, skin irritation, and delayed wound healing, especially for immunocompromised individuals.

Why it matters

Wound care products are essential for treating minor injuries, and microbial contamination can lead to serious health consequences if used by vulnerable populations. This recall highlights the importance of quality control and consumer safety in the medical products industry.

The details

The affected Revitaderm and Tridergel Wound Care Gel products were distributed nationwide to healthcare providers, not for retail or online sales. The lot numbers and expiration dates are printed on the bottom of the 1 oz. bottles and imprinted on the 3 oz. tube crimp. Blaine Labs has not received any reports of adverse events related to the recall.

  • The recall was initiated on April 8, 2026.

The players

Blaine Labs, Inc.

A pharmaceutical company that manufactures and distributes wound care products.

Lysinibacillus fusiformis

An environmental, spore-forming bacterium that was detected in the contaminated wound care gel products.

Got photos? Submit your photos here. ›

What’s next

Customers and healthcare providers should immediately stop using the affected products, segregate any remaining inventory, and contact Blaine Labs to arrange for the return of the recalled items.

The takeaway

This recall underscores the importance of stringent quality control measures in the medical products industry to ensure consumer safety, especially for vulnerable populations who rely on these products for wound care.